About this event

  • Date and time Wed 15 Sep 2021 from 8:30am to 4:30pm
  • Location Royal Society of Medicine
  • Organised by Cardiology

Join this in-person meeting that aims to provide an update on the latest Cardiology trials as well as offer a deep insight into the management of a complex cardiac condition that has been poorly understood. Cardiac Amyloid is under-diagnosed and under-treated, so this session will provide attendees with an understanding of how to recognise it and the new treatments available. The session will also provide an update on the rapidly growing field of Cardio-Oncology – a new branch of Cardiology that may provide Cardiology trainees new career opportunities. Designed for Cardiology trainees.

The session meets the curriculum requirements for Cardiology trainees at the ST3-7 level and will be of particular interest to trainees with an interest in Intervention, Electrophysiology, Heart Failure and Imaging. The session will be run by an experienced team of Consultant Cardiologists working across London.  

We hope you will join us in person for this event but if you are unable you can sign up for the live stream version here.

This session aims to:

  • Know the latest trial data in Interventional Cardiology 
  • Know the latest trial data in heart failure 
  • Know the latest trial data in electrophysiology 
  • Describe the epidemiology of cardiac amyloid 
  • Be able to diagnose cardiac amyloid 
  • Describe the treatment of cardiac amyloid 
  • Know the cardiac complications of cancer treatment 
  • Describe the imaging techniques used to monitor cardiac status on cancer treatment 

Join in the conversation online by using #RSMLive 
Follow us on Twitter: @RoySocMed



View the programme

Registration, tea and coffee
Welcome and introduction

Session 1

Cardiology Update

Session designed to give a clinical trials update over the last year 2020 / 2021

Interventional trials

Dr Rasha Al-Lamee

Question and answer session
Heart Failure trials

Amal Muthumala

Question and answer session
Electrophysiology trials

Dr Fu Siong

Question and answer session


Session 2

Amyloid session

ATTR and AL cardiomyopathy, true rare aetiologies of heart failure?


When to suspect cardiac amyloid in HF patients and how to diagnose : systemic and cardiac red flags and diagnostic pathways

Dr William Moody, Consultant Cardiologist, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust

New therapeutic option and clinical trials

Professor Ashutosh Wechalecar

Question and answer session
Tea and coffee break

Session 3

Cardio-Oncology talks

Imaging in cardio-oncology - the role of echocardiography and the new BSE-BCOS guidelines

Dr Rebecca Dobson

Question and answer session
Management of cardiotoxicity in breast cancer patients.

Dr Daniel Chen

Question and answer session
Arrhythmia in cancer patients

Dr Syed Ahsan 

Question and answer session
Cardiotoxicities of newer cancer therapies - the future now

Dr Arjun Ghosh 

Question and answer session

End of meeting


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Disclaimer: All views expressed at this event are of the speakers themselves and not of the RSM nor the speaker's organisations.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed  in future on various internet channels. 

Registration for this event will close at 12:00am on 14 September 2021.

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member